{
    "organizations": [],
    "uuid": "704ee6810e052b493c60b9af63901bbfc0d9a28d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kazia-therapeutics-receives-us-fda/brief-kazia-therapeutics-receives-u-s-fda-orphan-designation-for-drug-idUSFWN1QC1DS",
    "ord_in_thread": 0,
    "title": "BRIEF-Kazia Therapeutics Receives U.S. FDA Orphan Designation For Drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Kazia Therapeutics Ltd:\n* ‍ RECEIVES U.S. FDA ORPHAN DESIGNATION FOR DRUG FOR TREATMENT OF FORM OF PRIMARY BRAIN CANCER​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T12:37:00.000+02:00",
    "crawled": "2018-02-23T15:54:07.086+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "kazia",
        "therapeutic",
        "ltd",
        "receives",
        "fda",
        "orphan",
        "designation",
        "drug",
        "treatment",
        "form",
        "primary",
        "brain",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}